Carbery Group will be demonstrating its newly launched hydrolysed whey protein (WPH), Optipep 4Power, at the Fi Europe Connect virtual exhibition, which is scheduled to take place from 23 Nov-4 Dec 2020. In a clinical study, Carbery found that Optipep 4Power taken pre-workout enabled participants to generate more power for longer, compared with standard whey protein concentrate.
The hydrolysed whey protein has been developed to support nutritional strategies for high-intensity interval training (HIIT), which have been minimally research to date. Fi Europe attendees will have the opportunity to discover more about this new addition to the Carbery offering, as well as learning about the clinical research supporting it.
Carbery’s R&D team has developed the whey protein hydrolysate ingredients under the Optipep range, and used advanced mass spectrometry to analyse peptides in their latest ingredient. Data interpretation with bioinformatics enables them to identify possible bioactivity within the peptide sequences using predictor algorithms. Consequently, they were able to identify the protein with the possibility of having an impact on performance.
Sarah O’Neill, marketing manager at Carbery, concluded: “We’re thrilled to be participating in the virtual format of Fi Europe Connect, and are looking forward to interacting with attendees to share more information about Optipep 4Power and the clinical study supporting it. Using our technical expertise, we have been able to identify the optimal WPH and validate its potential positive impact on performance outcomes, and have shown that Optipep 4Power helps athletes produce and sustain more power compared to whey protein concentrate.
“Our experts will be on hand to talk to brands providing targeted nutritional solutions to consumers participating in HIIT sports about formulation support for what we believe is a game-changing product.”